Yousra Kherabi

ORCID: 0000-0002-6201-426X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Vaccine Coverage and Hesitancy
  • COVID-19 Clinical Research Studies
  • Infectious Diseases and Tuberculosis
  • COVID-19 diagnosis using AI
  • Mycobacterium research and diagnosis
  • Streptococcal Infections and Treatments
  • Bacterial Identification and Susceptibility Testing
  • HIV/AIDS drug development and treatment
  • Amoebic Infections and Treatments
  • Artificial Intelligence in Healthcare and Education
  • Antimicrobial Resistance in Staphylococcus
  • Global Maternal and Child Health
  • Hepatitis Viruses Studies and Epidemiology
  • Hepatitis C virus research
  • Machine Learning in Healthcare
  • Empathy and Medical Education
  • Pneumonia and Respiratory Infections
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pancreatitis Pathology and Treatment
  • Long-Term Effects of COVID-19
  • Digital Imaging for Blood Diseases
  • CAR-T cell therapy research

Université Paris Cité
2017-2025

Assistance Publique – Hôpitaux de Paris
2020-2025

Inserm
2017-2025

Université Claude Bernard Lyon 1
2021-2025

Sorbonne Paris Cité
2023-2025

Innovative Clinical Research
2024

Research Network (United States)
2024

Hôpital Paris Saint-Joseph
2023-2024

Hôpital Bichat-Claude-Bernard
2019-2024

Sorbonne Université
2017-2024

Vaccines are critical cost-effective tools to control the COVID-19 pandemic. However, emergence of more transmissible SARS-CoV-2 variants may threaten potential herd immunity sought from mass vaccination campaigns.The objective this study was provide an up-to-date comparative analysis characteristics, adverse events, efficacy, effectiveness and impact concern (Alpha, Beta, Gamma Delta) for fourteen currently authorized vaccines (BNT16b2, mRNA-1273, AZD1222, Ad26.COV2.S, Sputnik V,...

10.31219/osf.io/z4x7t preprint EN 2021-08-01

Staphylococci and streptococci are the most frequent pathogens isolated from prosthetic joint infections (PJIs). The aim of this study was to analyze outcome streptococcal methicillin-susceptible Staphylococcus aureus (MSSA) PJIs.All monomicrobial MSSA PJIs managed in a French Referral Center (2010-2017) were sampled prospective cohort study. primary interest cumulative reinfection-free survival at 2-year follow-up.Two hundred nine patients with 91 132 staphylococcal analyzed. Patients PJI...

10.1186/s12879-022-07532-x article EN cc-by BMC Infectious Diseases 2022-06-17

Abstract Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant (XDR have been updated. Pre–XDR TB, defined as MDR TB with additional to fluoroquinolones, XDR bedaquiline or linezolid, are frequently associated treatment failure toxicity. We retrospectively determined the effects pre-XDR/XDR on outcomes safety France. The study included 298 patients treated for at 3 reference centers during 2006–2019. Of those, 205 (68.8%) cases were...

10.3201/eid2809.220458 article EN cc-by Emerging infectious diseases 2022-08-22

Acquired thrombotic thrombocytopenic purpura is a rare and severe disease characterized by auto-antibodies directed against "A Disintegrin And Metalloproteinase with Thrombospondin type 1 repeats, 13th member" (ADAMTS13), plasma protein involved in hemostasis. Involvement of CD4+ T cells the pathogenesis suggested IgG isotype antibodies. However, nature T-cell epitopes remains poorly characterized. Here, we determined HLA-DR-restricted ADAMTS13. Candidate were predicted silico binding...

10.3324/haematol.2015.136671 article EN cc-by-nc Haematologica 2017-07-27
Coming Soon ...